Press release | 05 July 2024 Intellectual property and trade Tuberculosis South Africa MSF and Health Justice Initiative welcome J&J’s withdrawal of patents on lifesaving TB drug in South Africa
Photo credit: Jose Cendon The GeneXpert machine can identify the bacteria responsabile for tuberculosis (Mycobacterium tuberculosis) and also drug resistant TB Press release Press release | 17 June 2024 Diagnostics Danaher continues to charge exorbitant prices for lifesaving medical tests despite urgent demands for price reductions by several Ministries of Health 4 min
Copyright: Bruno De Cock Press release Press release | 06 June 2024 Tuberculosis Europe Urgent call for Europe to improve treatment access for tuberculosis 5 min
Photo credit: MSF/Chris Allan Press release Press release | 04 June 2024 Pandemic preparedness MSF responds to the outcomes of PPR negotiations at WHA77 2 min
Photo credit: Johnny Vianney Bissakonou/MSF Press release Press release | 04 June 2024 Vaccines NEWS UPDATE: Gavi’s next strategy must make sure to reach the 10 million children in fragile and humanitarian settings who are missing vaccines 3 min
Photo credit: Carmen Yahchouchi/MSF Press release Press release | 08 May 2024 Diabetes New MSF report shows unacceptable global double standard in diabetes care, even though better treatments cost little to produce and could be much more affordable 6 min
Photograph by Alexandra Sadokova Press release Press release | 25 April 2024 Transparency Research and development Tuberculosis In precedent-setting move towards drug-development cost transparency, MSF reveals cost of its landmark TB clinical trial: €34 million 6 min
Photo credit: Marta Soszynska/MSF Press release Press release | 24 April 2024 HIV/AIDS Intellectual property and trade Colombia issues first-ever compulsory license, a landmark step for expanding access to affordable HIV treatment 4 min
